SOLVENTUM CORP (SOLV) Stock Fundamental Analysis

NYSE:SOLV • US83444M1018

74.2 USD
-2.74 (-3.56%)
At close: Feb 27, 2026
74.2 USD
0 (0%)
After Hours: 2/27/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

SOLV gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 185 industry peers in the Health Care Equipment & Supplies industry. SOLV has a medium profitability rating, but doesn't score so well on its financial health evaluation. SOLV has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year SOLV was profitable.
  • SOLV had a positive operating cash flow in the past year.
  • Of the past 5 years SOLV 4 years were profitable.
  • SOLV had a positive operating cash flow in 4 of the past 5 years.
SOLV Yearly Net Income VS EBIT VS OCF VS FCFSOLV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 500M 1B 1.5B 2B

1.2 Ratios

  • With an excellent Return On Assets value of 10.91%, SOLV belongs to the best of the industry, outperforming 94.59% of the companies in the same industry.
  • SOLV has a better Return On Equity (30.57%) than 98.92% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 5.13%, SOLV is in the better half of the industry, outperforming 76.22% of the companies in the same industry.
  • SOLV had an Average Return On Invested Capital over the past 3 years of 9.85%. This is in line with the industry average of 8.75%.
  • The 3 year average ROIC (9.85%) for SOLV is well above the current ROIC(5.13%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 10.91%
ROE 30.57%
ROIC 5.13%
ROA(3y)7.62%
ROA(5y)N/A
ROE(3y)13.05%
ROE(5y)N/A
ROIC(3y)9.85%
ROIC(5y)N/A
SOLV Yearly ROA, ROE, ROICSOLV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 5 10 15

1.3 Margins

  • Looking at the Profit Margin, with a value of 18.14%, SOLV belongs to the top of the industry, outperforming 94.05% of the companies in the same industry.
  • In the last couple of years the Profit Margin of SOLV has declined.
  • SOLV's Operating Margin of 8.44% is fine compared to the rest of the industry. SOLV outperforms 75.14% of its industry peers.
  • In the last couple of years the Operating Margin of SOLV has declined.
  • SOLV has a Gross Margin of 54.18%. This is comparable to the rest of the industry: SOLV outperforms 50.81% of its industry peers.
  • In the last couple of years the Gross Margin of SOLV has declined.
Industry RankSector Rank
OM 8.44%
PM (TTM) 18.14%
GM 54.18%
OM growth 3Y-16.68%
OM growth 5YN/A
PM growth 3Y-31.26%
PM growth 5YN/A
GM growth 3Y-2.48%
GM growth 5YN/A
SOLV Yearly Profit, Operating, Gross MarginsSOLV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SOLV is destroying value.
  • SOLV has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
SOLV Yearly Shares OutstandingSOLV Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 50M 100M 150M
SOLV Yearly Total Debt VS Total AssetsSOLV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 5B 10B

2.2 Solvency

  • SOLV has an Altman-Z score of 1.96. This is not the best score and indicates that SOLV is in the grey zone with still only limited risk for bankruptcy at the moment.
  • SOLV has a Altman-Z score (1.96) which is in line with its industry peers.
  • The Debt to FCF ratio of SOLV is 102.74, which is on the high side as it means it would take SOLV, 102.74 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of SOLV (102.74) is better than 66.49% of its industry peers.
  • A Debt/Equity ratio of 1.03 is on the high side and indicates that SOLV has dependencies on debt financing.
  • SOLV's Debt to Equity ratio of 1.03 is on the low side compared to the rest of the industry. SOLV is outperformed by 76.76% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF 102.74
Altman-Z 1.96
ROIC/WACC0.51
WACC10.02%
SOLV Yearly LT Debt VS Equity VS FCFSOLV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

  • A Current Ratio of 1.50 indicates that SOLV should not have too much problems paying its short term obligations.
  • SOLV's Current ratio of 1.50 is on the low side compared to the rest of the industry. SOLV is outperformed by 75.14% of its industry peers.
  • SOLV has a Quick Ratio of 1.14. This is a normal value and indicates that SOLV is financially healthy and should not expect problems in meeting its short term obligations.
  • SOLV's Quick ratio of 1.14 is on the low side compared to the rest of the industry. SOLV is outperformed by 71.35% of its industry peers.
Industry RankSector Rank
Current Ratio 1.5
Quick Ratio 1.14
SOLV Yearly Current Assets VS Current LiabilitesSOLV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 1B 2B 3B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • SOLV shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.82%.
EPS 1Y (TTM)-8.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%11.35%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-3.66%

3.2 Future

  • SOLV is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.21% yearly.
  • The Revenue is expected to grow by 0.78% on average over the next years.
EPS Next Y6.14%
EPS Next 2Y7.42%
EPS Next 3Y9.21%
EPS Next 5YN/A
Revenue Next Year-3.21%
Revenue Next 2Y-0.01%
Revenue Next 3Y1.29%
Revenue Next 5Y0.78%

3.3 Evolution

SOLV Yearly Revenue VS EstimatesSOLV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B
SOLV Yearly EPS VS EstimatesSOLV Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 12.16, which indicates a correct valuation of SOLV.
  • Compared to the rest of the industry, the Price/Earnings ratio of SOLV indicates a rather cheap valuation: SOLV is cheaper than 92.97% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.10, SOLV is valued rather cheaply.
  • With a Price/Forward Earnings ratio of 11.46, the valuation of SOLV can be described as very reasonable.
  • Based on the Price/Forward Earnings ratio, SOLV is valued cheaply inside the industry as 91.89% of the companies are valued more expensively.
  • SOLV is valuated cheaply when we compare the Price/Forward Earnings ratio to 28.06, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 12.16
Fwd PE 11.46
SOLV Price Earnings VS Forward Price EarningsSOLV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SOLV indicates a rather cheap valuation: SOLV is cheaper than 84.86% of the companies listed in the same industry.
  • 67.03% of the companies in the same industry are more expensive than SOLV, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 257.4
EV/EBITDA 13.68
SOLV Per share dataSOLV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The decent profitability rating of SOLV may justify a higher PE ratio.
PEG (NY)1.98
PEG (5Y)N/A
EPS Next 2Y7.42%
EPS Next 3Y9.21%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • SOLV does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SOLVENTUM CORP

NYSE:SOLV (2/27/2026, 8:04:00 PM)

After market: 74.2 0 (0%)

74.2

-2.74 (-3.56%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-26
Earnings (Next)05-06
Inst Owners72.36%
Inst Owner ChangeN/A
Ins Owners0.13%
Ins Owner Change0.32%
Market Cap12.87B
Revenue(TTM)N/A
Net Income(TTM)1.52B
Analysts75.24
Price Target91.16 (22.86%)
Short Float %2.48%
Short Ratio3.57
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.87%
Min EPS beat(2)2.66%
Max EPS beat(2)15.09%
EPS beat(4)4
Avg EPS beat(4)7.48%
Min EPS beat(4)2.66%
Max EPS beat(4)15.09%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.07%
Min Revenue beat(2)-0.05%
Max Revenue beat(2)0.19%
Revenue beat(4)2
Avg Revenue beat(4)0%
Min Revenue beat(4)-0.81%
Max Revenue beat(4)0.68%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.82%
PT rev (3m)5.87%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.12%
EPS NY rev (1m)0%
EPS NY rev (3m)1.32%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.09%
Valuation
Industry RankSector Rank
PE 12.16
Fwd PE 11.46
P/S 1.53
P/FCF 257.4
P/OCF 26.11
P/B 2.58
P/tB N/A
EV/EBITDA 13.68
EPS(TTM)6.1
EY8.22%
EPS(NY)6.47
Fwd EY8.73%
FCF(TTM)0.29
FCFY0.39%
OCF(TTM)2.84
OCFY3.83%
SpS48.44
BVpS28.75
TBVpS-14.4
PEG (NY)1.98
PEG (5Y)N/A
Graham Number62.81
Profitability
Industry RankSector Rank
ROA 10.91%
ROE 30.57%
ROCE 6.43%
ROIC 5.13%
ROICexc 6.03%
ROICexgc 29.65%
OM 8.44%
PM (TTM) 18.14%
GM 54.18%
FCFM 0.6%
ROA(3y)7.62%
ROA(5y)N/A
ROE(3y)13.05%
ROE(5y)N/A
ROIC(3y)9.85%
ROIC(5y)N/A
ROICexc(3y)10.1%
ROICexc(5y)N/A
ROICexgc(3y)49.33%
ROICexgc(5y)N/A
ROCE(3y)12.33%
ROCE(5y)N/A
ROICexgc growth 3Y-14.04%
ROICexgc growth 5YN/A
ROICexc growth 3Y-12.55%
ROICexc growth 5YN/A
OM growth 3Y-16.68%
OM growth 5YN/A
PM growth 3Y-31.26%
PM growth 5YN/A
GM growth 3Y-2.48%
GM growth 5YN/A
F-Score6
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF 102.74
Debt/EBITDA 4.17
Cap/Depr 84.87%
Cap/Sales 5.27%
Interest Coverage 250
Cash Conversion 40.05%
Profit Quality 3.28%
Current Ratio 1.5
Quick Ratio 1.14
Altman-Z 1.96
F-Score6
WACC10.02%
ROIC/WACC0.51
Cap/Depr(3y)54.53%
Cap/Depr(5y)N/A
Cap/Sales(3y)3.74%
Cap/Sales(5y)N/A
Profit Quality(3y)131.71%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%11.35%
EPS Next Y6.14%
EPS Next 2Y7.42%
EPS Next 3Y9.21%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-3.66%
Revenue Next Year-3.21%
Revenue Next 2Y-0.01%
Revenue Next 3Y1.29%
Revenue Next 5Y0.78%
EBIT growth 1Y-45.71%
EBIT growth 3Y-16.4%
EBIT growth 5YN/A
EBIT Next Year17.61%
EBIT Next 3Y6.99%
EBIT Next 5Y3.32%
FCF growth 1Y-50.46%
FCF growth 3Y-25.22%
FCF growth 5YN/A
OCF growth 1Y-38.12%
OCF growth 3Y-18.66%
OCF growth 5YN/A

SOLVENTUM CORP / SOLV FAQ

Can you provide the ChartMill fundamental rating for SOLVENTUM CORP?

ChartMill assigns a fundamental rating of 4 / 10 to SOLV.


What is the valuation status of SOLVENTUM CORP (SOLV) stock?

ChartMill assigns a valuation rating of 6 / 10 to SOLVENTUM CORP (SOLV). This can be considered as Fairly Valued.


Can you provide the profitability details for SOLVENTUM CORP?

SOLVENTUM CORP (SOLV) has a profitability rating of 6 / 10.


How financially healthy is SOLVENTUM CORP?

The financial health rating of SOLVENTUM CORP (SOLV) is 3 / 10.